These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7964893)

  • 21. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of metals with the risk and clinical characteristics of Parkinson's disease.
    Kim MJ; Oh SB; Kim J; Kim K; Ryu HS; Kim MS; Ayton S; Bush AI; Lee JY; Chung SJ
    Parkinsonism Relat Disord; 2018 Oct; 55():117-121. PubMed ID: 29891430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased serum selenium concentrations in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Arrieta FJ; Aguilar MV; Cabrera-Valdivia F; Vázquez A; Jorge-Santamaría A; Seijas V; Fernández-Calle P; Martínez-Para MC
    Eur J Neurol; 1995 Apr; 2(2):111-4. PubMed ID: 24283610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid selenium and chromium levels in patients with Parkinson's disease.
    Aguilar MV; Jiménez-Jiménez FJ; Molina JA; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Gómez-Escalonilla C; Ort-Pareja M; Zurdo M; Martínez-Para MC
    J Neural Transm (Vienna); 1998; 105(10-12):1245-51. PubMed ID: 9928893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients.
    Molina JA; Benito-León J; Jiménez-Jiménez FJ; Ortí-Pareja M; Berbel A; Tallón-Barranco A; de Bustos F; Hernánz A
    Neurosci Lett; 1997 Dec; 238(3):139-41. PubMed ID: 9464639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease.
    Molina JA; de Bustos F; Jiménez-Jiménez FJ; Benito-León J; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Navarro JA; Arenas J; Enríquez-de-Salamanca R
    J Neural Transm (Vienna); 1997; 104(11-12):1287-93. PubMed ID: 9503274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters.
    Piao YS; Lian TH; Hu Y; Zuo LJ; Guo P; Yu SY; Liu L; Jin Z; Zhao H; Li LX; Yu QJ; Wang RD; Chen SD; Chan P; Wang XM; Zhang W
    Sci Rep; 2017 Sep; 7(1):10547. PubMed ID: 28874701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
    Tórsdóttir G; Kristinsson J; Sveinbjörnsdóttir S; Snaedal J; Jóhannesson T
    Pharmacol Toxicol; 1999 Nov; 85(5):239-43. PubMed ID: 10608487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
    J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to long-term deferoxamine therapy in thalassemia.
    Cohen A; Martin M; Schwartz E
    J Pediatr; 1981 Nov; 99(5):689-94. PubMed ID: 7299539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.
    Hussain MA; Green N; Flynn DM; Hussein S; Hoffbrand AV
    Lancet; 1976 Dec; 2(7998):1278-80. PubMed ID: 63749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid nitrate levels in patients with Parkinson's disease.
    Molina JA; Jiménez-Jiménez FJ; Navarro JA; Vargas C; Gómez P; Benito-León J; Ortí-Pareja M; Cisneros E; Arenas J
    Acta Neurol Scand; 1996; 93(2-3):123-6. PubMed ID: 8741130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary hemochromatosis. Diagnosis in siblings and children.
    Edwards CQ; Carroll M; Bray P; Cartwright GE
    N Engl J Med; 1977 Jul; 297(1):7-13. PubMed ID: 865566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk.
    Costa-Mallen P; Zabetian CP; Agarwal P; Hu SC; Yearout D; Samii A; Leverenz JB; Roberts JW; Checkoway H
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1087-92. PubMed ID: 26228081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased ferritin levels in brain in Parkinson's disease.
    Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum iron and ferritin level in idiopathic Parkinson.
    Farhoudi M; Taheraghdam A; Farid GA; Talebi M; Pashapou A; Majidi J; Goldust M
    Pak J Biol Sci; 2012 Nov; 15(22):1094-7. PubMed ID: 24261127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels.
    Dale JC; Burritt MF; Zinsmeister AR
    Am J Clin Pathol; 2002 May; 117(5):802-8. PubMed ID: 12090432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low plasma uric acid level in Parkinson's disease.
    Annanmaki T; Muuronen A; Murros K
    Mov Disord; 2007 Jun; 22(8):1133-7. PubMed ID: 17443703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.